Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 12, 2010 07:30 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at 2010 GHS Healthcare Conference

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S. Jacob, the Company's President...
July 12, 2010 08:00 ET | Source: Synergy Pharmaceuticals

Callisto Pharmaceuticals Adjourns Annual Stockholders Meeting Due to Lack of a Quorum

NEW YORK--Callisto Pharmaceuticals, Inc. (OTCBB: CLSP.OB), announced today that it adjourned its annual stockholders' meeting held on July 9, 2010 due to lack of a quorum. The agenda for the...
April 27, 2010 07:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at 2010 BIO Business Forum in Chicago, IL

2010 BIO International Convention NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S....
March 19, 2010 08:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Initiates Phase IIa Clinical Trial of SP-304 in Patients with Chronic Constipation

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the initiation of dosing in a Phase IIa clinical...
January 22, 2010 08:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at the 8th Annual BioPartnering North America (BPN) Conference in Vancouver, BC, Canada

BioPartnering North America 2010 NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that Dr. Gary S....
November 12, 2009 08:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that it has completed a private placement in which...
October 08, 2009 08:30 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that on October 6, 2009 the Board of Directors of...
October 05, 2009 08:30 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference in London, UK

BioPartnering Europe 2009 NEW YORK--Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that management will...
July 07, 2009 07:15 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals Raises $7.09 Million in Common Stock Financing

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that it has completed the final tranche of its...
May 26, 2009 04:01 ET | Source: Synergy Pharmaceuticals

Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference

NEW YORK--Synergy Pharmaceuticals, Inc. (OTC BB: SGYP.OB SGY PNews), a developer of new drugs to treat gastrointestinal disorders and diseases, announced today that clinical data from the Phase I...